Literature DB >> 32527981

Activation of Peripheral and Central Trigeminovascular Neurons by Seizure: Implications for Ictal and Postictal Headache.

Agustin Melo-Carrillo1,2, Aaron J Schain1,2, Andrew M Strassman1,2, Rami Burstein3,2.   

Abstract

An epileptic seizure can trigger a headache during (ictal) or after (postictal) the termination of the event. Little is known about the pathophysiology of seizure-induced headaches. In the current study, we determined whether a seizure can activate nociceptive pathways that carry pain signals from the meninges to the spinal cord, and if so, to what extent and through which classes of peripheral and central neurons. To achieve these goals, we used single-unit recording techniques and an established animal model of seizure (picrotoxin) to determine the effects of epileptic seizure on the activity of trigeminovascular Aδ-, C-, wide-dynamic range, and high-threshold neurons in male and female rats. Occurrence of seizure activated 54%, 50%, 68%, and 39% of the Aδ-, C-, wide-dynamic range, and high-threshold neurons, respectively. Regardless of their class, activated neurons exhibited a twofold to fourfold increase in their firing, which started immediately (1 min) or up to 90 min after seizure initiation, and lasted as short as 10 min or as long as 120 min. Administration of lidocaine to the dura prevented activation of all neuronal classes but not the initiation or maintenance of the seizure. These findings suggest that all neuronal classes may be involved in the initiation and maintenance of seizure-induced headache, and that their activation patterns can provide a neural substrate for explaining the timing and duration of ictal and possibly postictal headaches. By using seizure, which is evident in humans, this study bypasses controversies associated with cortical spreading depression, which is less readily observed in humans.SIGNIFICANCE STATEMENT This preclinical study provides a neural substrate for ictal and postictal headache. By studying seizure effects on the activity of peripheral (C and Aδ) and central (wide dynamic range and high-threshold) trigeminovascular neurons in intact and anesthetized dura, the findings help resolve two outstanding questions about the pathophysiology of headaches of intracranial origin. The first is that abnormal brain activity (i.e., seizure) that is evident in human (unlike cortical spreading depression) gives rise to specific and selective activation of the different components of the trigeminovascular system, and the second is that the activation of all components of the trigeminovascular pathway (i.e., peripheral and central neurons) depends on activation of the meningeal nociceptors from their receptors in the dura.
Copyright © 2020 the authors.

Entities:  

Keywords:  headache; ictal headache; postictal headache; seizure; trigeminovascular system

Mesh:

Substances:

Year:  2020        PMID: 32527981      PMCID: PMC7329305          DOI: 10.1523/JNEUROSCI.0283-20.2020

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  41 in total

1.  Postictal headache in South African adult patients with generalised epilepsy in a tertiary care setting: a cross-sectional study.

Authors:  Stephanus Schmidt Botha; Clara-Maria Schutte; Steve Olorunju; Mandisa Kakaza
Journal:  Cephalalgia       Date:  2010-05-21       Impact factor: 6.292

Review 2.  Migraine: multiple processes, complex pathophysiology.

Authors:  Rami Burstein; Rodrigo Noseda; David Borsook
Journal:  J Neurosci       Date:  2015-04-29       Impact factor: 6.167

3.  Prevalence of epilepsy in rural Kansas.

Authors:  Elizabeth Ablah; Dale C Hesdorffer; Yi Liu; Angelia M Paschal; Suzanne Hawley; David Thurman; W Allen Hauser
Journal:  Epilepsy Res       Date:  2014-02-13       Impact factor: 3.045

4.  Spinothalamic and spinohypothalamic tract neurons in the cervical enlargement of rats. II. Responses to innocuous and noxious mechanical and thermal stimuli.

Authors:  R J Dado; J T Katter; G J Giesler
Journal:  J Neurophysiol       Date:  1994-03       Impact factor: 2.714

5.  Activation of central trigeminovascular neurons by cortical spreading depression.

Authors:  Xichun Zhang; Dan Levy; Vanessa Kainz; Rodrigo Noseda; Moshe Jakubowski; Rami Burstein
Journal:  Ann Neurol       Date:  2011-03-17       Impact factor: 10.422

6.  Seizure-associated headache in epilepsy.

Authors:  T Leniger; K Isbruch; S von den Driesch; H C Diener; A Hufnagel
Journal:  Epilepsia       Date:  2001-09       Impact factor: 5.864

7.  A comparison of post-ictal headache between patients with occipital lobe epilepsy and temporal lobe epilepsy.

Authors:  M Ito; F Nakamura; H Honma; Y Takeda; R Kobayashi; T Miyamoto; T Koyama
Journal:  Seizure       Date:  1999-09       Impact factor: 3.184

8.  Responses of spinothalamic tract cells to mechanical and thermal stimulation of skin in rats with experimental peripheral neuropathy.

Authors:  J Palecek; V Palecková; P M Dougherty; S M Carlton; W D Willis
Journal:  J Neurophysiol       Date:  1992-06       Impact factor: 2.714

9.  Headache in patients with epilepsy: a prospective incidence study.

Authors:  Patrick Kwan; Celeste B L Man; Howan Leung; Evelyn Yu; Ka S Wong
Journal:  Epilepsia       Date:  2008-03-21       Impact factor: 5.864

10.  Exploring the effects of extracranial injections of botulinum toxin type A on prolonged intracranial meningeal nociceptors responses to cortical spreading depression in female rats.

Authors:  Agustin Melo-Carrillo; Andrew M Strassman; Aaron J Schain; Rodrigo Noseda; Sait Ashina; Aubrey Adams; Mitchell F Brin; Rami Burstein
Journal:  Cephalalgia       Date:  2019-08-31       Impact factor: 6.292

View more
  1 in total

1.  Untargeted serum metabolomic profiling for early detection of Schistosoma mekongi infection in mouse model.

Authors:  Peerut Chienwichai; Kathyleen Nogrado; Phornpimon Tipthara; Joel Tarning; Yanin Limpanont; Phiraphol Chusongsang; Yupa Chusongsang; Kanthi Tanasarnprasert; Poom Adisakwattana; Onrapak Reamtong
Journal:  Front Cell Infect Microbiol       Date:  2022-08-18       Impact factor: 6.073

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.